Table 3.
Physical complications endorsed by participants for each condition.
| BED/obesity participants who indicated physical complication associated with BED n = 79 | Obesity-only participants who indicated physical complication associated with obesity n = 96 | ||||
|---|---|---|---|---|---|
| Physical Complication | n (%) | n (%) | χ2 | p | Phi |
| Electrolyte Imbalances (n = 20) | 17 (21.5) | 3 (3.1) | 14.49 | <0.001 | 0.29 |
| Autoimmune disorders (n = 11) | 4 (5.1) | 7 (7.3) | 0.37 | 0.76 | 0.05 |
| Bradycardia (n = 1) | 1 (1.3) | 0 (0.0) | 1.22 | 0.45 | 0.08 |
| Hypoglycemia (n = 6) | 2 (2.5) | 4 (4.2) | 36.70 | <0.001 | 0.46 |
| High blood pressure (n = 142) | 48 (60.8) | 94 (97.9) | 39.10 | <0.001 | 0.47 |
| Osteoporosis (n = 15) | 5 (6.3) | 10 (10.4) | 0.92 | 0.49 | 0.07 |
| High cholesterol (n = 145) | 54 (68.4) | 91 (94.8) | 21.33 | <0.001 | 0.35 |
| Chronic Kidney Problems of Kidney Failure (n = 41) | 10 (12.7) | 31 (32.3) | 8.25 | <0.05 | 0.22 |
| Osteoarthritis (n = 94) | 19 (24.1) | 75 (78.1) | 50.97 | <0.001 | 0.54 |
| Type II diabetes (n = 158) | 62 (78.5) | 96 (100) | 20.49 | <0.001 | 0.34 |
| Stroke (n = 73) | 21 (26.6) | 52 (54.2) | 13.56 | <0.001 | 0.28 |
| Irregular Menstrual Cycle (n = 95) | 41 (51.9) | 54 (56.3) | 0.33 | 0.65 | 0.04 |
| Skin Disorders (n = 68) | 28 (35.4) | 40 (41.7) | 0.71 | 0.44 | 0.06 |
| Tinnitus (n = 1) | 0 (0.0) | 1 (1.0) | 0.83 | 1.00 | 0.06 |
| Dental Erosion (n = 24) | 15 (19.0) | 9 (9.5) | 3.38 | 0.078 | 0.14 |
| Cardiovascular diseases (n = 136) | 43 (54.4) | 93 (96.9) | 45.08 | <0.001 | 0.51 |
| Sleep apnea (n = 129) | 39 (49.4) | 90 (93.8) | 44.06 | <0.001 | 0.51 |
| Polycystic ovary syndrome (n = 115) | 34 (43.0) | 81 (84.4) | 32.87 | <0.001 | 0.43 |
Bolded text denotes correct responses for each condition.